• Теги
    • избранные теги
    • Компании1939
      • Показать ещё
      Разное693
      • Показать ещё
      Страны / Регионы222
      • Показать ещё
      Международные организации23
      • Показать ещё
      Издания101
      • Показать ещё
      Показатели80
      • Показать ещё
      Формат35
      Люди119
      • Показать ещё
07 декабря, 15:11

Should Government Regulation End Indexing As We Know It?

An op-ed in The New York Times today lays out the case for imposing new restrictions on how index funds operate. The rationale, according to the authors, is to prevent the reduction in competition in industries that is a direct consequence of indexing. If the proposal is implemented as outlined, the indexing strategy for equity […]

07 декабря, 01:08

Are Traditional Convenience Stores Threatened by Amazon Go?

This new line of convenience stores introduced by e-commerce giant Amazon (AMZN) through its "Project Como" earlier this year has started to hog attention.

01 декабря, 17:26

Walgreens CEO Stefano Pessina: 'Consolidation Is A Good Thing For This Market'

Forbes Media executive vice president Moira Forbes with Walgreens Boots Alliance chief executive Stefano Pessina. (Stephen Kang/Pete Kolonia for Forbes) Consolidation is key for billionaire andWalgreens Boots Alliance CEO Stefano Pessina. "To be honest I believe consolidation is a good thing for this market," Pessinasaid, speaking at the Forbes Healthcare Summit in [...]

30 ноября, 17:12

Ten Years of a SHA(RED) Fight: An Interview with Bobby Shriver

Ten years ago I was in Lesotho and Rwanda with Bobby Shriver, Bono, Sir Richard Feachem and others committed to fighting HIV/AIDS in Africa. We came together through Product (RED), an innovative idea that joined NGOs, governments, health care experts, global brands and celebrities to raise awareness and funding toward the bold goal of eliminating HIV/AIDS in Africa. As a part of the Gap (RED) launch team, I got to see first-hand the need that existed as well as the hope that new treatments provided, if only the funding were available. As we celebrate World AIDS Day and the 10-year anniversary of Product (RED), I had an opportunity to interview one of (RED)'s founders, Bobby Shriver - an activist, journalist, philanthropist and civic leader - to take a look at the progress made fighting HIV/AIDS in Africa. The (RED) team in Rwanda in 2006 for the launch of Product (RED). From left to right: Bobbi Silten from Gap Inc., David Maddocks from Converse, Leslie Dance from Motorola, Bobby Shriver, Bono, Tamsin Smith from (RED) and Dan Henkle from Gap Inc. 1. In the first 10 years of (RED) what was accomplished and what do the next 10 years look like? Our biggest accomplishment has been to bring this issue to people in their hometowns. Before (RED), the scale of the pandemic was known mostly in public health circles. (RED) told the story to the broad population and they have responded! (RED) is now a global brand, which is the result of a lot of hard work and tremendous partnerships. That was the critical first step. The next step, particularly in the new political era we are entering, is to make sure that people support this life saving work without any political agenda. We always found that people from all political backgrounds saw this medicine as non-partisan, humanitarian work. As an American, I found it very American to just say, "we're going to do it," and get the medicine to the people who need it to stay alive. And my Irish partner, the great Bono, always said that the idea of America is an international idea. It means the moon shot, trying for the impossible and making it happen. Because hundreds of children are born every day with this terrible virus, we have to keep at that idea. In the ten years since (RED)'s launch, we have earned more than $365 million to support the Global Fund. The money finances HIV/AIDS grants in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania, and Zambia. Millions of people are alive today because they receive medicine from these investments. They are able to take care of their children and contribute to their communities. Yet, in the spread and transmission of HIV, there are still 400 babies born every day with a preventable virus. 2. The spread of HIV/AIDS has slowed but there is still no cure. How do you keep people motivated and engaged in the fight to end AIDS? Unlike some issues, this is a winnable fight. When we started (RED), only 2.1 million people had access to the necessary medicine. But once people understood it took only two pills a day to keep people alive, they supported the fight. And of course, the (RED) products were great and people bought them! Now, 18 million people receive the critical treatment they need and many of them do because people bought a Gap t-shirt, or an Apple iPhone case or another great (RED) product. How great is that? 3. You've spent time in Africa working alongside change-makers and champions. What lessons have they taught you? Listening and listening carefully is the biggest lesson for me. Folks who want and need help know how they would like to be served. Too often care is prescribed by smart people or organizations that are far away from the problem (might have been me!). I am almost never surprised by how little I know. And I know the Global Fund team has this perspective. That's why they have been so effective. 4. Ten years ago, Product (RED) was unique in the way it brought together global brands, celebrities and consumers with health experts, NGOs and governments to address the AIDS emergency. How did you come up with the idea to engage brands in a global health epidemic? The harsh fact is, when we dreamt (RED) up we were desperate. We had promised American government leaders that the private sector would become involved. That was NOT happening. And the government folks called us on it! "You guys promised us..." We needed a complete rethink. But it was hard to get people to see our vision. We had 40 meetings and 36 companies said "no." The four founding brands were very brave. We knew that brands had the marketing expertise and could tell powerful stories, so they would be essential in our effort to raise awareness. 5. Looking back on the last ten years of (RED) what would you have done differently? I would have had more staff at the beginning. We had a huge launch on Oprah Winfrey's shopping spree show in 2006. On the day Oprah and Bono walked Chicago's "Magnificent Mile" visiting stores -- including Gap, Apple, Armani and Motorola -- to feature (RED) products, we had nine staff. The next day, 45 companies called us, including CEOs of major brands. Calls were streaming in. They wanted to join us or wanted a meeting. Of course, we moved fast but couldn't do it all, so we lost some opportunities. 6. You have dedicated your life to activism, philanthropy and public service. What advice do you have for young activists and social entrepreneurs starting their careers today? A lot of people find their work by being angry at injustice. Make your anger work for you! My mother always told me stories about the mistreatment of her "special" sister, Rosemary, who was excluded from places and events. The treatment of her sister really made my mother mad because she knew it was very unfair. I saw that anger motivate her to do many positive things that benefitted others, including starting the Special Olympics for people with intellectual disabilities. I felt a similar anger when I realized that so many people were going to die because they lacked medicine. They did not have a Walgreens or CVS where they could fill a prescription. And because of that, they were going to die. It offended me. I became very, very determined to get that medicine for folks. To learn more about Product (RED) and the fight against AIDS visit red.org. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

29 ноября, 11:19

Руперт Мердок потерял $100 млн, инвестировав в стартап Theranos

На старте в Theranos вкладывали деньги инвесторы из Кремниевой долины. Но большую часть средств глава Theranos Элизабет Холмс получила от крупных инвесторов, не связанных напрямую с медицинским бизнесом, сообщает издание со ссылкой на свои источники. В их числе оказался и Руперт Мердок, владелец СМИ, кинокомпаний и издательств в США, Австралии, Европе, Латинской Америке и Азии. Руперт Мердок отказался от комментариев. Тем временем Роберт Колман, инвестор из Кремниевой долины подал иск против Theranos, за "ложные и вводящие в заблуждение заявления о своих технологиях и вымогательство денег у инвесторов". Как сообщалось ранее, крупнейшая американская аптечная сеть Walgreens в начале ноября также обратилась с судебным иском против Theranos. По утверждению биотехнологической компании Theranos, она разработала технологию, позволяющую делать анализы на основе нескольких капель крови. Сомнения в эффективности метода начались после публикации статьи в The Wall Street Journal в октябре 2015 года. Со ссылкой на нескольких бывших работников компании Wall Street Journal утверждала, что метод не отличается достоверностью.

29 ноября, 01:38

Robertson Stephens Co-Founder Sues Theranos And Elizabeth Holmes For Fraud

In what is not the first lawsuit (and certainly won't be the last) by naive shareholders to go after former unicorn darling-turned-fraud Theranos, its founder Elizabeth Holmes, and COO Ramesh Balwani, the co-founder of prominent dot com investment bank Robertson Stephens, Robert Colman, accused Theranos and Holmes of making false and misleading claims about its operations and technology while soliciting money from investors. The pioneering Silicon Valley deal maker invested in the blood-testing company in late 2013 through venture-capital fund Lucas Venture Group, according to the lawsuit. The suit was filed in federal court in San Francisco and seeks class-action status. The WSJ first reported of the legal action. In the lawsuit Colman says that he agreed to invest in Theranos after Lucas Venture Group founder Donald A. Lucas wrote in a Sept. 9, 2013, letter that Theranos invited the venture-capital firm to purchase $15 million in stock. As the WSJ adds, Lucas said it was part of a “follow-on extension” of a funding round that began in 2010, the lawsuit states. On the same day in 2013, Theranos and Walgreens announced in a joint news release what they called “a long-term partnership to bring access to Theranos’ new lab testing service through Walgreens pharmacies nationwide.” Walgreens is now a unit of Walgreens Boots Alliance Inc. From the filing: Companies owe a duty to potential investors to be open and honest. Even non-public companies are bound by this principle of frankness no matter how sophisticated their potential investors might be. Specifically, those who solicit investments for a company should not make statements that are designed to reach potential investors that are materially false, misleading or incomplete. Those who make statements to investors must believe them to be true and complete, have a reasonable basis for their belief, and exercise reasonable care and not know of any untruth or omission.   Plaintiffs bring this action because Theranos, Inc. (“Theranos”), Chief Executive Officer Elizabeth Holmes (“Holmes”), and former President and Chief Operating Officer Ramesh “Sunny” Balwani (“Balwani”) flaunted these simple rules. To them, being honest and forthright was an obstacle to their goals. Instead, beginning in July 2013, Theranos, Holmes and Balwani set in motion a widespread publicity campaign whose purpose was raising billions for Theranos and themselves and to induce investors to invest in Theranos. They told the public, knowing and intending that their statements would reach potential investors, that they had perfected “a proprietary” and “revolutionary technology” over the past ten years that would change the world of laboratory testing.   Holmes claimed that Theranos’ proprietary technology could take a pinprick’s worth of blood, extracted from the tip of a finger instead of intravenously, and test for hundreds of diseases—a remarkable innovation that was going to save millions of lives and, in a phrase that Holmes often repeated, “Change the world.” Based on this story, Defendant also claimed that this technology had been vetted or was being vouched for by clinics, pharmaceutical companies, experts, regulators and an all-star board of directors. And they announced that the technology was immediately being rolled-out by one of the nation’s largest drug store chains, Walgreens.   Holmes honed her story to near perfection. She gave hundreds of interviews in which she promoted her narrative about Theranos’ revolutionary technology. She bolstered that story by  attracting to the Theranos Board of Directors luminaries like Henry Kissinger and George Schultz. Holmes adorned the covers of Fortune, Forbes and other publications and promoted her message there and elsewhere. She also amassed a net worth of around $9 billion.   The truth—there was no revolutionary technology. On October 15, 2015, the Wall Street Journal (WSJ) shocked the investing world with a story that Theranos was “struggling” with turning this technology into a reality. According to the WSJ, Theranos’ employees were “leery about the machine’s accuracy” and the machine was being used for a tiny number of tests. The article also reported that some doctors didn’t trust the test results they were receiving. While Theranos vigorously attacked and denied the WSJ article and follow-on media reports—calling them “factually and scientifically erroneous and grounded in baseless assertions by inexperienced and disgruntled former employees and industry incumbents”—those reports have turned out to be largely true. Reportedly, Theranos is under investigation by the United States Department of Justice (U.S. DOJ) and the Securities and Exchange Commission (SEC). According to the WSJ, Colman, who has retired from investment banking and lives in Idaho, declined to comment through his lawyer. Theranos and Lucas Venture Group didn’t immediately respond to requests for comment. Walgreens declined to comment. The lawsuit also includes a second plaintiff, Hilary Taubman-Dye, who alleges that she bought Theranos shares on the online exchange SharesPost Inc., which acts as a broker for shares of private companies. Taubman-Dye allegedly agreed to buy Theranos stock at a price of $19 a share in August 2015. She tried to cancel the transaction after The Wall Street Journal published in October 2015 its first article detailing problems at Theranos. At the time, Theranos, founder Elizabeth Holmes and an unidentified third party all had a legal right of first refusal giving them a chance to buy any shares an investor chose to sell in a secondary transaction, the suit alleges. The full lawsuit is presented below

28 ноября, 18:45

Как открытый API влияет на бизнес

Зарубежные компании, в том числе банки, движутся по пути создания более открытой ИТ-экосистемы: они постепенно превращаются в технологические платформы. Открытые API способны не только заметно сократить процесс разработки, но и ускорить вывод новых решений на рынок.

28 ноября, 18:45

Как открытый API влияет на бизнес

Зарубежные компании, в том числе банки, движутся по пути создания более открытой ИТ-экосистемы: они постепенно превращаются в технологические платформы. Открытые API способны не только заметно сократить процесс разработки, но и ускорить вывод новых решений на рынок.

28 ноября, 18:45

Как открытый API влияет на бизнес

Зарубежные компании, в том числе банки, движутся по пути создания более открытой ИТ-экосистемы: они постепенно превращаются в технологические платформы. Открытые API способны не только заметно сократить процесс разработки, но и ускорить вывод новых решений на рынок.

28 ноября, 18:15

5 Case Studies to Get Your Client on Board With Retail and Licensing Partnerships

If you've seen the headlines lately, you know that this is the worst of times for retailers. Chains from Walgreens to Walmart are downsizing, while others, like Sports Authority and Loehmann's, are shuttering. Yet, to paraphrase Charles Dickens, these are also the best of times for retailers -- if they know where to look. If you're looking to license your brand -- if you want to develop genuine partnerships with the world's leading retailers -- then you need to think like a retailer. You need to understand the factors that matter most to their business, and then plan your pitch accordingly. Few brands have pulled off this balancing act better than Ford. When the company's beloved Mustang turned 50, Ford teamed up with five of America's top retailers to create new channels for distribution, and thus new customers. Let's study how they did it. 1. Lucky Jeans Lucky Brand Jeans is an American denim company. You've likely seen their pants at the mall -- each one has stitched onto the outside of the fly the phrase, "Lucky You." But the mall isn't a place where a lot of cars are sold. And that's a missed opportunity for an all-American company like Ford, whose role in U.S. history surely deserves a seat at the table of this storied shopping venue. Hence, the Ford-Lucky partnership, in which Lucky manufactures Ford-branded clothing. The resulting T-shirts combine the masculine virtues that made cars like the Mustang classics with the slub fabric for which Lucky is known. (Sample slogan: "Mess with the best. Lose with the rest.") 2. Cracker Barrel When most people go to a restaurant, they go for the food. We licensing experts view the world through an additional lens: we look at the clientele. Accordingly, when our licensing team visited a Cracker Barrel, the chain of restaurants that remind you of a traditional country store, one thing immediately stood out: the parking lot. Is it just me, we asked one another, or was it full of Explorers and Escapes and Mustangs and trucks? Clearly, Cracker Barrel customers were also Ford customers. No surprise, then, that these two American institutions teamed up to create a contest to win a new Mustang V6. The sweepstakes went viral, spreading through social media, e-newsletters for employees and loyalty customers, and in-store point-of-sale systems. And a no-brainer tie-in, a Ford-branded collection of merchandise was added to Cracker Barrel's gift shops. "When the Mustang turned 50, many companies wanted in on the anniversary of the original pony car, but we had to be choosy, finding a partner that really got it," recalls Betsy McKelvey, Ford's marketing manager of global brand licensing. "Our collaboration with Cracker Barrel shows how much can be accomplished when the right licensee meets the right licensor." 3. Uniqlo What do T-shirts from Japan have to do with cars from Detroit? More than you might think -- especially for two conglomerates that operate on a global landscape. Uniqlo, meet Ford Motor Company. The Japanese fast-fashion company is one of today's hottest clothing makers. Ford, of course, is one of the world's oldest carmakers. Together, they complement one another's strengths, striking a blow for originality. (Indeed, "Uniqlo" is a portmanteau of "unique clothing.") Through the ensuing Ford-logoed apparel, fathers can coolly channel their Motor City nostalgia, while their sons are introduced to the company that brought mankind the Model T. Oh yeah, in the process, over 150,000 T shirts were sold. 4. Microsoft "If you're the kind of person who likes racing fast cars in video games, then it's no surprise you'd enjoy tooling around in a sports car in real life," says Mark Bentley, Ford's licensing manager. So, when Microsoft released Forza Motorsport 6 -- one of the all-time top games for Xbox -- it was only natural to partner with the manufacturer of one of today's top racing vehicles. That manufacturer would be Ford, and the vehicle would be the recently redesigned GT, which was crowned Forza's cover car. If you're a gamer, you know that being named the cover car is a big deal. Car companies around the world covet this honor because of the priceless exposure it presents to die-hard car fans. Not only does Ford get its car on the game's cover and in Microsoft's marketing materials -- both of which are sold at hot retailers like GameStop -- but players also start each ride with the GT as their default vehicle. Ditto the benefits for Microsoft, whose staff were some of the only people outside Motor City who even know the GT existed. (In fact, they saw the model before many Ford execs did.) Once these techies spied the sleek supercar in Ford's top-secret R&D lab, they knew the deal was a sure winner. Finally, there was the matter of the all-important reveal. Taking a page from Steve Jobs, executives who worked on the deal knew that because the product was a supercar, they needed a super announcement -- a dramatic entrance worthy of ultra-high performance, advanced aerodynamics, and lightweight carbon fiber. Hence the descent from the rafters at the Electronic Entertainment Expo of the stunningly beautiful and rip-roaringly powerful automobile. Gamers, start your engines. 5. OPI Who says a muscle car is only for men? Surely not a lacquer company -- after all, what does nail polish have to do with an automobile? A lot, it turns out. The color of a woman's nails is ultimate expression of her personality, explains Suzi Weiss-Fischmann, cofounder of OPI. Similarly, color plays a key role in defining the character of a car; to capture the Mustang's essence, its paint colors need to denote performance, sportiness, and power. Thus, the lacquers created for the OPI Ford Mustang limited-edition collection are bold and eye-catching. Indeed, the names themselves are terrifically expressive: Race Red. 50 Years of Style. Queen of the Road. Girls Love Ponies. Angel with a Leadfoot. And the Sky's My Limit. Each hue celebrates a woman's pursuit of adventure and embraces the spirit of the open road. The shades are sold everywhere from Amazon and JCPenney to Regis and ULTA to drug and specialty stores. And if you missed the media coverage in magazines such as Cosmopolitan, Elle, Essence, InStyle, Marie Claire, and People, you might have seen the ads on the Jumbotron in Times Square. For five decades, Ford Mustang has represented the best of American culture. Yet as retail is shrinking, publicity is getting harder and harder to come by. The way forward is not merely to license your brand, but to build and invest in alliances with licensee partners. Find those that shared your vision, and broker an exclusive deal with them. Then watch as your news clips start lighting up your Google Alerts, your retail footprint expands, and your sales skyrocket. Jeff Lotman is the founder and chief executive of Global Icons, a brand-licensing agency. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

28 ноября, 15:58

Walgreen Boots: Mixed Q4, Awaits Rite Aid Deal Closure

On Nov 25, 2016, we issued an updated research report on Deerfield, IL-based Walgreens Boots Alliance, Inc. (WBA).

25 ноября, 16:41

Rite Aid (RAD) Focuses on Strategic Growth: Time to Hold?

Rite Aid (RAD) remains confident of sustaining its growth momentum with its focus on cost management and strengthening of its portfolio of health and wellness services.

Выбор редакции
23 ноября, 02:39

That May Not Be Aloe Vera You're Applying, Report Says

First, there were reports of wood pulp in grated cheese. And now, this.  A new Bloomberg News report raises doubts about store-brand aloe vera after tests it commissioned on products bought at Walmart, CVS and Target reportedly found no trace of their claimed prime ingredient ― aloe barbadensis leaf juice. Instead, the products were said to have contained cheaper maltodextrin, a sugar used as a food additive that Bloomberg said can imitate aloe. Three gels identified as failing Bloomberg’s tests are Walmart’s Equate Aloe After Sun Gel with pure aloe vera; CVS’ Aftersun Aloe Vera Moisturizing Gel; and Target’s Up & Up Aloe Vera Gel with pure aloe vera. Walgreens’ Alcohol-Free Aloe Vera Body Gel was reportedly found to contain one of aloe’s three chemical makers, malic acid. Acemannan and glucose were not found, which Bloomberg said means the presence of aloe could neither be confirmed nor ruled out. The report comes months after a class-action lawsuit was filed against the Texas-based company that manufactures aloe products for Walgreens, Walmart and Target. That company, Fruit of the Earth, responded to Bloomberg’s article by calling it utterly false. The company argued in a statement to The Huffington Post that acemannan doesn’t equate to aloe, but said its tests nevertheless show Fruit of the Earth products do contain the chemical maker. The company said it would share its test results in the class-action litigation. “The true test of whether the product contains aloe is to trace the aloe ingredient from the aloe leaves, through processing, and to the manufacturer’s use of the aloe ingredient in the finished product,” the company said. As for the presence of maltodextrin, Fruit of the Earth said a production step “uses maltodextrin to aid in the spray drying process.” Walmart and CVS appear to be taking their supplier’s word. A Walmart spokesman said in an email to HuffPost that the retailer would continue to sell the product. A spokeswoman for Target declined comment, citing the litigation. Aloe vera, which contains vitamins, anti-inflammatory enzymes, fatty acids and minerals, has a range of health benefits. Acemannan has shown anti-inflammatory and anti-bacterial properties, and appears to promote cell growth, studies have shown. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

18 ноября, 14:04

CVS Health (CVS): Sluggish Q3, Guidance Cut Pose Concerns

On Nov 18, 2016, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).

Выбор редакции
Выбор редакции
14 ноября, 15:37

Despite Walgreens, CVS Clinics, Hospital ERs Still Used For Routine Care

Retail clinics owned by CVS, Walgreens and Wal-Mart have become a popular choice for routine aliments and quick primary care treatment, but they may not be reducing visits to emergency departments, a RAND Corp. analysis indicates

Выбор редакции
09 ноября, 16:49

Wednesday's Morning Email: The Aftermath Of A Trump Triumph

TOP STORIES DONALD TRUMP IS THE NEXT PRESIDENT OF THE UNITED STATESTake a look at how the GOP nominee funneled discontent into a win no one saw coming. The political outsider broke all the rules, took the White House and reshaped the electoral map and the future of the country along the way. World leaders have already begun reaching out to the new leader of the free world. Hillary Clinton called Trump to concede early this morning but has yet to address the election results publicly. Clinton could still win the popular vote ― she is currently leading by a razor-thin margin. And President Barack Obama has already begun to hand over the reins to Trump. Watch Trump’s victory speech, and read the full results from Election Day. [Sam Stein, HuffPost] WHY WE’RE DROPPING OUR DONALD TRUMP EDITORIAL NOTE “Where we find fault in how Trump governs, we won’t hesitate to call it out ... But we have hope that the man we saw on the trail at his worst moments is not the man who will enter the White House.” [Ryan Grim, HuffPost] THE MARKETS DIDN’T TAKE KINDLY TO THE PRESIDENTIAL UPSETTrading on Nasdaq and S&P futures was frozen last night after falling rapidly in response to the presidential news. The dollar fell, while gold and the Japanese yen are on the rise. And here’s where Trump’s win leaves U.S. businesses. [Daniel Marans, HuffPost] HOW ALL THE POLLSTERS AND FORECASTERS GOT THIS WRONGSo very wrong. Howard Fineman breaks down how 2016 became another”Dewey defeats Truman” moment for the media. [Natalie Jackson and Ariel Edwards-Levy, HuffPost] DON’T FORGET ABOUT THE SENATE AND THE HOUSE D.C. is completely red. Republicans retained control of the Senate, holding onto what is currently a 51-seat majority that is likely to grow to 53 once all the votes are finalized, with the House also set to stay red. And Sean Hannity warned that Paul Ryan may not be Speaker of the House come January. [Michael McAuliff, HuffPost] OR BALLOT INITIATIVES From marijuana to the minimum wage. [Matt Ferner and Nick Wing, HuffPost] AND THE CANADIAN IMMIGRATION SITE CRASHED ON ELECTION NIGHT For no reason at all ... but Lin-Manuel Miranda reminded the country why that’s not the right attitude. As did Jonathan Chait, who wrote: “Forget Canada. Stay and fight for American democracy.” [Jesselyn Cook, HuffPost] WHAT’S BREWING AT LEAST WE STILL HAVE DUMBLEDORE The old faithful we all grew up with is returning in the “Fantastic Beasts And Where To Find Them” franchise. [HuffPost]  ALL THE FAMOUS PEOPLE VOTING SELFIES Remind yourself that your vote counted just as much as theirs. And that their social media outbursts also mirrored yours. [HuffPost] MEET THE OTHER MARK ZUCKERBERG The one not worth billions. [Backchannel] LIFE WITH THE HYPERLOOP “You’re in Dubai, and you need to get to Abu Dhabi, roughly 100 miles away, so you bring up an app on your phone. A few minutes later, a self-driving pod pulls up at your door, brings you to a portal, and docks inside a transporter tube. When you get to Abu Dhabi, the pod undocks and drives you directly to your destination. Door to door, the trip takes about 15 minutes.” [Fast Company] NO ONE REALLY KNOWS WHAT’S HAPPENING IN THE ANGELINA JOLIE-BRAD PITT CUSTODY BATTLE Some say she has full custody, other outlets are reporting that’s just an extension. [HuffPost] WALGREENS IS GOING AFTER THERANOS There is no good news left for this disgraced Silicon Valley darling. [HuffPost]  BEFORE YOU GO ~ So ... how cool do we need to be to be invited to a Taylor Swift-thrown birthday party? T-Swift, help The Morning Email out. ~ These photos of dogs voting got us through the longest Election Day ever. ~ The solace you find in drug stores, in between the nail polish remover and paper towels. ~ More on how to “MacGyver” your car. ~ This New York Times graphic on the race’s “screeching U-turn” is worth a look. ~ A history of candidates who won the popular vote but lost the electoral map ― and thus the presidency. ~ Here’s a glimpse at what Prince Harry’s girlfriend Meghan Markle thinks about ladies who lunch. ~ We’ve got you covered when it comes to Thanksgiving ― check out the best canned pumpkin for all those pies you’re about to make. ~ What to do if you’re overwhelmed by the election. ~ Of course Trump has updated his Twitter bio. ~ And here’s what newspaper front pages around the world look like this morning after Trump’s surprise win.     Send tips/quips/quotes/stories/photos/events/scoops to Lauren [email protected] Follow us on [email protected] Does somebody keep forwarding you this newsletter?Get your own copy. It’s free! Sign up here. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

09 ноября, 16:21

Dear Queer America: Here Is What We Must Do Now That Trump Will Be President

I went to bed last night before Donald Trump was officially the named the next president of the United States because I didn’t know what else to do with myself. The anxiety was too palpable. The dread was too real. I felt like my soul had left my body and was repeatedly banging itself against my living room ceiling in an attempt to knock itself unconscious.  I woke up up at 3:00 am thinking that Tuesday night had been some kind of sick dream, as if I were a character at the end of a badly written horror movie who learns the monster was merely a figment of his imagination. But I wasn’t dreaming ― we aren’t dreaming ― and this isn’t the end of horror movie. It’s just the beginning. So, what do we do now? How do we, as queer people, move forward knowing so many people ― our families, our friends, our neighbors, our coworkers ― who live in a country that’s supposed to believe in and protect liberty and freedom and justice just voted for a man who is so rabidly anti-woman, anti-people of color, anti-immigrant, anti-queer and who is so obviously so unfit to lead this country? How do we look them in the face and not want to cry or spit or throw punches? I don’t really know. What I do know, is that no matter how lonely you feel right now while you’re reading this at your desk or lying in your bed or waiting in line at Walgreens, you are not alone. There are millions of you ― of us ― searching for uneasy answers, trying not to breakdown on the subway, forcing ourselves to pull our shirts over our heads and attempt to somehow be useful in a country that seems to have no use for us, in a country that we are certain does not want us, that we worry will not keep us safe. For now, we must hold each other as we fall to pieces, as we simultaneously lose ourselves to our despair and drown in our panic, as we burn with the hottest, bluest flames of hopelessness. And then we must hold each other as we piece ourselves back together, as we remember who we are ― who we have always been ― and remember what we have stared down and refused to give in to before. Remember what we and those who came before us have overcome, together, for hundreds and hundreds of cold, dark years. We must, perhaps more than any time before now, be exactly who we are, not by denying our fears, but by willingly pumping them through our veins as proof that we exist despite the very real dreams of those who wish we did not. Let those fears fuel us as we remind ourselves and anyone who dare look upon us that we are not going anywhere ― that we are wholly deserving of our love and our desire simply because they are real and they are ours and they have made us who we are today. Let us be furious. Let us be afraid. Let us tell ourselves everything will somehow be OK and then let us believe it and then let us make it so. If you haven’t come out, come out. If you have come out, come out again and again and again ― to your families, to the officials who have been elected to represent you, to the woman sitting next to you on your flight to San Diego.  Let us be heartbroken. Let us be doubtless. Let us learn and relearn and teach each other our history and let us never allow ourselves or each other to forget. Let us vote. Let us donate our time and our money and our attention to those who may have even less than us and even more reasons to be terrified than we do. Let us be vigilant. Let us be brave. Let us give ourselves and anyone else as many orgasms as we can muster with our bare hands and our open mouths and our beautiful, quivering bodies and let us understand how radical of an act this truly is. Let us fall in love with ourselves or anyone else at any given moment ― just because we can, just because ― look at us! How could we not? Let us be rooted. Let us be decisive. Let us refuse to hear “no” but be unafraid to say it. Let us look for moments to offer mercy to ourselves and anyone else. Let us hold those who have wronged us accountable for their actions and their words. Let us not fear righteous anger or the very real power it can have to get things done. Let us know when and how to forgive and when and how not to. Let us see ― truly see. Let us speak what needs to be spoken. Let us wake up and stay awake today and every day after today. Let us fight alongside one another with our words and our actions and our hearts and let us never stop fighting, even when we’re telling ourselves and each other that the end of the world has finally arrived ― even when the end of the world finally arrives. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

Выбор редакции
09 ноября, 11:15

Аптечная сеть Walgreens требует у Theranos $140 млн

Согласно договору с Theranos, сеть открыла лаборатории для анализов в 40 аптеках в Фениксе и северной части Калифорнии. В будущем компания намеревалась запустить тестирование по технологии Theranos в тысячах аптек по всей стране. Walgreens прекратила сотрудничество с компанией Элизабет Холмс в июне нынешнего года, заявив, что "внимательно рассмотрела свои отношения с Theranos и считает, что прекращение партнёрских отношений — в интересах наших клиентов". Представитель Walgreens рассказал Gizmodo, что иск подан в штате Делавэр, но отказался обсуждать другие подробности. По утверждению биотехнологической компании Theranos, она разработала технологию, позволяющую делать анализы буквально на основании нескольких капель крови. Сомнения в эффективности метода начались после публикации статьи в The Wall Street Journal в октябре 2015 года. Со ссылкой на нескольких бывших работников компании Wall Street Journal утверждала, что метод не отличается достоверностью. Кроме того, утверждалось, что в ряде исследований Theranos использует традиционные методы анализа, вводя в заблуждение клиентов и инвесторов.